|
Jul 15
|
Abivax Provides Operational and Key Program Update
|
|
Feb 13
|
Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th Congress of European Crohn’s and Colitis Organization (ECCO)
|
|
Oct 24
|
Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market
|
|
Aug 10
|
Abivax Announces Plans to Conduct Registered Public Offering in the United States
|